Reaction profile

The FDA adverse-event record for viral skin infection nos

Name: Viral skin infection NOS - FDA Animal Adverse Reaction
Creator: PlainBreed
License: https://open.fda.gov/license/

12 FDA reports name viral skin infection nos, a lower-volume reaction in the CVM extract (VeDDRA 1869). Plate stamps and neighbourhood peers follow.

#2404 of 2,481
by report volume (all reactions): 12
reports citing this reaction: 0.0%
death-coded share: Dog
most-affected species

Compiled by PlainBreed

Verify with FDA CVM →

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Viral skin infection NOS has 12 reports now versus 12 in that prior snapshot: 0 the same number of (0.0%).

Report change: +0
Death-coded reports: +0
Death-coded share: +0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Viral skin infection NOS changes

FDA AER · VeDDRA plate

Code 1869 VOL-TRACE

VOL-TRACE · DEATH-RARE · BOTTOM-DECILE · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

VOL-TRACE 12 reports
DEATH-RARE 0.0%
BOTTOM-DECILE #2404/2481
PHOTO-FINISH Agitated state of mind
SPECIES-DOG Dog · 10
DRUG-LEAD Oclacitinib Malea… · 8
DESK-WIDE 9 breeds
BOOK-FULL 8/8 fields

Nearest volume peer: Agitated state of mind (±0 reports)

Instrument codes from this reaction’s FDA CVM adverse-event extract: volume band, death-coded share, corpus rank, photo-finish peer, lead species, lead drug, breed desk, and book completeness. Not a clinical diagnosis.

Lower-volume neighbourhood around Viral skin infection NOS

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

FDA AER report volume · neighbourhood around Viral skin infection NOS

Viral skin infection NOS: low death-coded share in the FDA AER plate

Signature read: 12 reports place Viral skin infection NOS in the lower third of FDA AER volume (#2404 of 2,481). Report volume is lower-third scale: 12 named reports in the openFDA extract. Death-coded share is lower-third: 0 of 12 reports (0.0% of named reports). Nearest volume peer: Agitated state of mind (±0 reports). Lead species Dog (10). Lead co-reported drug Oclacitinib Maleate (8).

Read these counts as reporting volume, not risk: per our methodology, Lead co-reported drug Oclacitinib Maleate appears in filings alongside this reaction; that is association, not causation. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 10

Cat 1

Horse 1

Breeds Most Affected

Crossbred Canine/dog 2

Schnauzer - Miniature 2

Chihuahua 2

Terrier - Bull - Staffordshire 1

Shih Tzu 1

Bulldog - American 1

Domestic Shorthair 1

Bulldog - French 1

Unknown 1

Associated Drugs

Oclacitinib Maleate 8

Carprofen 2

Milbemycin Oxime + Spinosad 1

Cyclosporine 1

Bexagliflozin 1

Prednisolone 1

Ilunocitinib 1

Vaccine (Unknown) 1

Isoflurane 1

Sevoflurane 1

Clindamycin 1

Amoxi/Clav (Unspecified) 1

What to do with this reaction

Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
Browse the full reaction directory to compare report counts across reaction types. All reactions

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Viral skin infection NOS (#2404 of 2,481 by report volume); death-coded 0.0%. PlainBreed reaction plate · report volume stamp 12 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →